The relation between gastroesophageal reflux and respiratory symptoms in a population-based study: The Nord-Trøndelag health survey

Chest

Volumn 129, Issue 4, 2006, Pages 1051-1056

  Nordenstedt, Helena ^a   Nilsson, Magnus ^a   Johansson, Saga ^b   Wallander, Mari Ann ^b   Johnsen, Roar ^c   Hveem, Kristian ^d   Lagergren, Jesper ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^d HUNT Research Centre   (Norway)

Author keywords

Asthma; Epidemiology; Gastroesophageal reflux; Respiratory symptoms

Indexed keywords

ADULT; AGED; ARTICLE; ASTHMA; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; COUGHING; DISEASE ASSOCIATION; DYSPNEA; EPIDEMIOLOGICAL DATA; FEMALE; GASTROESOPHAGEAL REFLUX; HEALTH SURVEY; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NORWAY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; STATISTICAL SIGNIFICANCE; SYMPTOM; WHEEZING;

EID: 33645967478     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.129.4.1051     Document Type: Article

References (35)

1. Locke GR III, Talley NJ, Fett SL, et al. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology 1997; 112:1448-1456
2. Nilsson M, Johnsen R, Ye W, et al. The prevalence of gastroesophageal reflux among adults. Scand J Gastroenterology 2004; 39:1040-1045
3. Dent J, El-Serag HB, Wallander MA, et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005; 54:710-717
4. Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999; 340:825-831
5. Sundelof M, Ye W, Dickman PW, et al. Improved survival in both histologic types of oesophageal cancer in Sweden. Int J Cancer 2002; 99:751-754
6. Ofman JJ. The economic and quality-of-life impact of symptomatic gastroesophageal reflux disease. Am J Gastroenterol 2003; 98(Suppl):S8-S14
7. Kulig M, Leodolter A, Vieth M, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease: an analysis based on the ProGERD initiative. Aliment Pharmacol Ther 2003; 18:767-776
8. Eloubeidi MA, Provenzale D. Health-related quality of life and severity of symptoms in patients with Barrett's esophagus and gastroesophageal reflux disease patients without Barrett's esophagus. Am J Gastroenterol 2000; 95:1881-1887
9. Henke CJ, Levin TR, Henning JM, et al. Work loss costs due to peptic ulcer disease and gastroesophageal reflux disease in a health maintenance organization. Am J Gastroenterol 2000; 95:788-792
10. Field SK, Underwood M, Brant R, et al. Prevalence of gastroesophageal reflux symptoms in asthma. Chest 1996; 109:316-322
11. Kiljander TO, Laitinen JO. The prevalence of gastroesophageal reflux disease in adult asthmatics. Chest 2004; 126:1490-1494
12. Nilsson M, Johnsen R, Ye W, et al. Obesity and estrogen as risk factors for gastroesophageal reflux symptoms. JAMA 2003; 290:66-72
13. DeVault KR, Castell DO. Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Am J Gastroenterol 1999; 94:1434-1442
14. Locke GR, Talley NJ, Weaver AL, et al. A new questionnaire for gastroesophageal reflux disease. Mayo Clin Proc 1994; 69:539-547
15. Shaw MJ, Talley NJ, Beebe TJ, et al. Initial validation of a diagnostic questionnaire for gastroesophageal reflux disease. Am J Gastroenterol 2001; 96:52-57
16. Revicki DA, Wood M, Wiklund I, et al. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res 1998; 7:75-83
17. Klauser AG, Schindlbeck NE, Müller-Lissner SA. Symptoms of gastro-esophageal reflux disease. Lancet 1990; 335:205-208
18. Patterson RN, Johnston BT, MacMahon J, et al. Oesophageal pH monitoring is of limited value in the diagnosis of "reflux-cough." Eur Respir J 2004; 24:724-727
19. Weiss ST. Obesity: insight into the origins of asthma. Nat Immunol 2005; 6:537-539
20. El-Serag HB, Sonnenberg A. Comorbid occurrence of laryngeal or pulmonary disease with esophagitis in United States military veterans. Gastroenterology 1997; 113:755-760
21. Ruhl CE, Sonnenberg A, Everhart JE. Hospitalisation with respiratory disease following hiatal hernia and reflux esophagitis in a prospective, population-based study. Ann Epidemiol 2001; 11:477-483
22. Field SK, Evans JA, Price LM. The effects of acid perfusion of the esophagus on ventilation and respiratory sensation. Am J Respir Crit Care Med 1998; 157:1058-1062
23. Harding SM. Gastroesophageal reflux, asthma, and mechanisms of interaction. Am J Med 2001; 111(Suppl):8S-12S
24. Phua SY, McGarvey LP, Ngu MC, et al. Patients with gastro-oesophageal reflux disease and cough have impaired laryngopharyngeal mechanosensitivity. Thorax 2005; 60:488-491
25. Lagergren J, Bergström R, Adami HO, et al. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med 2000; 133:165-175
26. Stein MR, Towner TG, Weber RW, et al. The effect of theophylline on the lower esophageal sphincter pressure. Ann Allergy 1980; 45:238-241
27. 2-adrenergic agonist on lower esophageal function: a dose-response study. Chest 2001; 120:1184-1189
28. 2-adrenergic agonist on lower esophageal sphincter pressure in normals and in patients with achalasia. Dig Dis Sci 1982; 27:1063-1066
29. Avidan B, Sonnenberg A, Schnell TG, et al. Temporal associations between coughing or wheezing and acid reflux in asthmatics. Gut 2001; 49:767-772
30. Harding SM, Richter JE, Guzzo MR, et al. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 1996; 100:395-405
31. Kiljander TO, Salomaa ER, Hietanen EK, et al. Gastroesophageal reflux in asthmatics: a double-blind, placebo-controlled crossover study with omeprazole. Chest 1999; 116:1257-1264;
32. erratum, Chest 2001; 120:691
33. Levin TR, Sperling RM, McQuaid KR. Omeprazole improves peak expiratory flow rate and quality of life in asthmatics with gastroesophageal reflux. Am J Gastroenterol 1998; 93:1060-1063
34. Field SK, Gelfand GA, McFadden SD. The effects of antireflux surgery on asthmatics with gastroesophageal reflux. Chest 1999; 116:766-774
35. Kiljander T. Efficacy of esomeprazole 40 mg twice daily for 16 weeks in adults with asthma: a randomized placebo-controlled trial [abstract]. ERS Annual Congress, September 17-21, 2005; Copenhagen, Sweden.